C

우리바이오

082850KOSDAQ기타 식품 제조업

46.8 / 100

Reference Date: 2026-06-10

Financial Score12.5 / 40
News Sentiment21.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Plunged 30.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Ourbio operates five business segments, including health functional foods, FPCB and electronic components, LED modules, real estate, and nanofiber fabrics. It is actively expanding its health functional food market through brands like 'Solutio' and 'Harutin,' while the FPCB segment benefits from growing demand in smart devices and automotive industries. The company is also expanding into bio-related fields, such as medical cannabis research.

Number of Employees

95people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 13.214.0Point
PBR
0.27Industry Average 0.567.0Point

Half of industry avg (excellent)

ROE
-3.84Industry Average 2.720.0Point

Well below industry avg

Debt Ratio
18.87Industry Average 11.910.5Point

1.6x industry avg (risky)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼8.9% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼67.6% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 2.4% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 1,430Won52-week high 2,49052-week low 1,430
1-month return0.0Point

1m -30.92% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0
  • Neutral주주명부폐쇄기간또는기준일설정2026-06-08
  • Neutral주주총회소집결의2026-06-08
  • Neutral주식병합결정2026-06-08
  • Neutral분기보고서 (2026.03)2026-05-15